Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
生物类似药胰岛素门冬预混剂 SAR341402 Mix 70/30 与原研胰岛素门冬混合剂 70/30 (NovoMix 30) 在糖尿病患者中的疗效比较：一项为期 26 周的随机、开放标签试验 (GEMELLI M)
期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-022-01255-7
Aravind, S R; Singh, Kiran P; Aquitania, Grace; Mogylnytska, Liliia; Zalevskaya, Alsu G; Matyjaszek-Matuszek, Beata; Wernicke-Panten, Karin; Nguyên-Pascal, My-Liên; Pierre, Suzanne; Rotthaeuser, Baerbel; Kramer, Daniel; Mukherjee, Bhaswati
